Darren I. O'Brien

Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoter.

Gabriela Kalna, Tim Crook, Catharine M L West, 2010, The Journal of clinical investigation.

Targeting the Fas/Fas ligand pathway in cancer

F. Shanahan, J. O'Connell, Darren I. O'Brien, 2005, Expert opinion on therapeutic targets.

Upregulation of Neurokinin-1 Receptor Expression in the Lungs of Patients with Sarcoidosis

F. Shanahan, M. Bennett, J. O'Connell, 2003, Journal of Clinical Immunology.

The role of substance P in inflammatory disease

F. Shanahan, J. O'Connell, Darren I. O'Brien, 2004, Journal of cellular physiology.

Transforming Growth Factor-β Directly Induces p53-up-regulated Modulator of Apoptosis (PUMA) during the Rapid Induction of Apoptosis in Myc-driven B-cell Lymphomas*

Jian Yu, G. Inman, M. Cragg, 2012, The Journal of Biological Chemistry.

Rapid development of a quantitative-competitive (qc) RT-PCR assay using a composite primer approach.

A. Ryan, M. Bennett, J. O'Connell, 2002, Methods in molecular biology.

Activation of the p38 MAPK and ERK1/2 Pathways Is Required for Fas‐Induced IL‐8 Production in Colonic Epithelial Cells

F. Shanahan, J. O'Connell, Darren I. O'Brien, 2002, Annals of the New York Academy of Sciences.

Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoter.

Jonathan A. Cooper, A. Harris, L. Nicholson, 2010, The Journal of clinical investigation.